603590.SS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 03:00):

Stats
Today's Volume	942 400
Average Volume	1.77M
Market Cap	4.41B
EPS	CNY0 ( 2024-04-08 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	30.46
ATR14	CNY0.0310 (0.11%)

Volume Correlation

Long: 0.22 (neutral)

Short: 0.40 (neutral)

Signal:(44.742) Neutral

Beijing Konruns Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Beijing Konruns Correlation - Currency/Commodity

0.38
( neutral )

0.23
( neutral )

0.00
( neutral )

0.36
( neutral )

0.65
( moderate )

0.01
( neutral )

Beijing Konruns Financials

Annual	2022
Revenue:	CNY866.73M
Gross Profit:	CNY740.57M (85.44 %)
EPS:	CNY0.650

Q3	2023
Revenue:	CNY269.20M
Gross Profit:	CNY243.46M (90.44 %)
EPS:	CNY0.360

Q2	2023
Revenue:	CNY285.73M
Gross Profit:	CNY255.83M (89.54 %)
EPS:	CNY0.430

Q1	2023
Revenue:	CNY165.11M
Gross Profit:	CNY147.52M (89.35 %)
EPS:	CNY0.160

Financial Reports:

No articles found.

Beijing Konruns

Beijing Konruns Pharmaceutical Co.,Ltd. engages in the research, production, and sale of various drugs in China. The company offers Su Ling product in the hemagglutinin preparation market used to reduce bleeding during surgery and control postoperative surgery. It also engages in the development of drug candidates, including CX1026, CX1003, and KC1036. The company was founded in 2003 and is headquartered in Beijing, China.